Stay updated on Nivo/Ipil Immunotransplant in DLBCL Clinical Trial
Sign up to get notified when there's something new on the Nivo/Ipil Immunotransplant in DLBCL Clinical Trial page.

Latest updates to the Nivo/Ipil Immunotransplant in DLBCL Clinical Trial page
- Check2 days agoNo Change Detected
- Check9 days agoChange DetectedThe web page has been updated from version 2.16.1 to version 2.16.2.SummaryDifference0.3%
- Check16 days agoChange DetectedThe web page has been updated to indicate that the ClinicalTrials.gov data ingest will be modernized in June 2025, allowing API users to provide input before implementation. Additionally, the revision number has been updated from v2.15.2 to v2.16.1.SummaryDifference2%
- Check23 days agoNo Change Detected
- Check45 days agoChange DetectedThe web page has been updated from version 2.15.0 to version 2.15.2, indicating a revision in the content.SummaryDifference0.1%
- Check52 days agoChange DetectedDifference0.4%
- Check59 days agoChange DetectedThe webpage has been updated to reflect a new version of a clinical trial for relapsed/refractory diffuse large B-cell lymphoma, including changes in the principal investigator's name and the revision number. The details regarding the trial's inclusion criteria and the study's collaborative partner have also been modified.SummaryDifference51%
- Check66 days agoChange DetectedThe web page has been updated from version 2.14.3 to version 2.14.4.SummaryDifference0.1%
Stay in the know with updates to Nivo/Ipil Immunotransplant in DLBCL Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Nivo/Ipil Immunotransplant in DLBCL Clinical Trial page.